These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8005373)

  • 21. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
    Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
    Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
    J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
    Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
    Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.
    di Salle E; Giudici D; Briatico G; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1993 Nov; 46(5):549-55. PubMed ID: 8240976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans.
    Cook JC; Klinefelter GR; Hardisty JF; Sharpe RM; Foster PM
    Crit Rev Toxicol; 1999 Mar; 29(2):169-261. PubMed ID: 10213111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hyper- and hypoprolactinemia on gonadotropin secretion, rat testicular luteinizing hormone/human chorionic gonadotropin receptors and testosterone production by isolated Leydig cells.
    Waeber C; Reymond O; Reymond M; Lemarchand-Beraud T
    Biol Reprod; 1983 Feb; 28(1):167-77. PubMed ID: 6299412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).
    Prahalada S; Tarantal AF; Harris GS; Ellsworth KP; Clarke AP; Skiles GL; MacKenzie KI; Kruk LF; Ablin DS; Cukierski MA; Peter CP; vanZwieten MJ; Hendrickx AG
    Teratology; 1997 Feb; 55(2):119-31. PubMed ID: 9143092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response.
    Waalkes MP; Rehm S; Devor DE
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):40-6. PubMed ID: 9007032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 5 alpha-reductase activity impairs the testosterone-dependent restoration of spermiogenesis in adult rats.
    O'Donnell L; Stanton PG; Wreford NG; Robertson DM; McLachlan RI
    Endocrinology; 1996 Jul; 137(7):2703-10. PubMed ID: 8770889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
    Stoner E
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA
    Cancer Res; 1980 Apr; 40(4):1006-13. PubMed ID: 7357531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of testicular and somatic development after treatment of the postnatal rat with the Leydig cell cytotoxic ethylene dimethanesulphonate.
    Morris ID; Lendon RG; Zaidi A
    J Endocrinol; 1988 Dec; 119(3):467-74. PubMed ID: 2851639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment.
    Lephart ED
    Neurobiol Aging; 1995; 16(4):647-50. PubMed ID: 8544916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Leydig cell hyperplasia in adult rats with low T and high LH induced by prenatal Di(n-butyl) phthalate exposure.
    Wakui S; Takahashi H; Mutou T; Shirai M; Jutabha P; Anzai N; Wempe MF; Kansaku N; Hano H; Inomata T; Endou H
    Toxicol Pathol; 2013; 41(3):480-6. PubMed ID: 22968287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway.
    Soni KK; Shin YS; Choi BR; Karna KK; Kim HK; Lee SW; Kim CY; Park JK
    Drug Des Devel Ther; 2017; 11():2969-2979. PubMed ID: 29066868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct testicular 17-ketosteroid reductases, one in interstitial tissue and one in seminiferous tubules. Differential modulation by testosterone and metabolites of testosterone.
    Murono EP; Payne AH
    Biochim Biophys Acta; 1976 Oct; 450(1):89-100. PubMed ID: 10012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine investigations in two cases of feminizing Leydig cell tumour.
    Valensi P; Coussieu C; Kemeny JL; Attali JR; Amouroux J; Sebaoun J
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):365-72. PubMed ID: 3113148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.